Patents by Inventor Christopher McIntyre

Christopher McIntyre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12496384
    Abstract: A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
    Type: Grant
    Filed: December 15, 2023
    Date of Patent: December 16, 2025
    Assignee: DSRCo BV
    Inventors: Jeffrey Testani, Christopher McIntyre, Ian Crosbie, Oliver Goedje
  • Publication number: 20240115785
    Abstract: A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 11, 2024
    Applicant: Sequana Medical NV
    Inventors: Jeffrey TESTANI, Christopher McINTYRE, Ian CROSBIE, Oliver GOEDJE
  • Patent number: 11844890
    Abstract: A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
    Type: Grant
    Filed: January 20, 2023
    Date of Patent: December 19, 2023
    Assignee: Sequana Medical NV
    Inventors: Jeffrey Testani, Christopher McIntyre, Ian Crosbie, Oliver Goedje
  • Publication number: 20230158221
    Abstract: A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
    Type: Application
    Filed: January 20, 2023
    Publication date: May 25, 2023
    Applicant: Sequana Medical NV
    Inventors: Jeffrey TESTANI, Christopher McINTYRE, Ian CROSBIE, Oliver GOEDJE
  • Patent number: 11559618
    Abstract: A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
    Type: Grant
    Filed: May 2, 2022
    Date of Patent: January 24, 2023
    Assignee: Sequana Medical NV
    Inventors: Jeffrey Testani, Christopher McIntyre, Ian Crosbie, Oliver Goedje
  • Publication number: 20220257843
    Abstract: A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
    Type: Application
    Filed: May 2, 2022
    Publication date: August 18, 2022
    Applicant: Sequana Medical NV
    Inventors: Jeffrey TESTANI, Christopher McINTYRE, Ian CROSBIE, Oliver GOEDJE
  • Publication number: 20200138372
    Abstract: The invention provides early feedback to clinician or caregiver so that they may characterize the adequacy of the cardiorespiratory system over short-term time intervals. In that way, any deficiencies may be readily detected and treated before the patient's compensatory capacity is compromised. In one embodiment, a biological signal, having a waveform, is processed for deriving a perfusion parameter and a baseline value for the perfusion parameter. The invention monitors, in real time, the derived perfusion parameter and determines a variation of the computed perfusion parameter from the baseline value. The determined variation of the derived perfusion parameter is evaluated with respect to at least one variation threshold. A duration of time associated with the determined variation is measured that is reflective of the amount of time the derived perfusion parameter variation is above or below the at least one variation threshold.
    Type: Application
    Filed: January 3, 2020
    Publication date: May 7, 2020
    Inventors: Anne Brumfield, Christopher McIntyre, Marcus Mianulli
  • Patent number: 9435179
    Abstract: A collection device for collecting oil and gas that is placed near the sea floor over a leak or seep. The device is anchored to the seabed. It has a long body and a head into which oil and gas can flow and be captured. An extraction system is attached to the collector that utilizes long tubes to collect both the oil and gas and bring them to the surface. The collector can be used singly or it can be combined with many others to form a complete collection system.
    Type: Grant
    Filed: September 21, 2011
    Date of Patent: September 6, 2016
    Inventors: Christopher McIntyre, Roy Longacre
  • Patent number: T102603
    Abstract: A table syrup is disclosed consisting essentially of an aqueous phase containing at least about 65% sugar having emulsified therein about 1 to 40% butter, based on the total emulsion weight and about 0.05 to 0.4% of a stabilizer consisting of 20-35% pectin, 35-50% carrageenan, 15-30% locust bean gum, and 5-20% potassium citrate. Such syrups are much more easily homogenized than are presently known syrups of this type and are characterized by good stability of the oil droplet throughout the aqueous phase.
    Type: Grant
    Filed: January 14, 1980
    Date of Patent: January 4, 1983
    Assignee: Hercules Incorporated
    Inventor: Christopher McIntyre